Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 13, 2015 5:14 AM ET


Company Overview of Intercell Ag

Company Overview

As of May 28, 2013, Intercell Ag was acquired by Vivalis. Intercell AG, a biotechnology company, develops and commercializes novel immunomodulatory biologicals to prevent disease and reduce suffering worldwide. Its technology platforms include the patch-based vaccine delivery system and the proprietary human monoclonal antibody discovery system, eMAB. It offers Japanese Encephalitis, an inactivated vaccine indicated for active immunization for the prevention of disease caused by the Japanese Encephalitis virus in adults under the IXIARO and JESPECT brand names. Intercell AG’s Japanese Encephalitis vaccine is also completed Phase III clinical trial for pediatric use in non-endemic markets. Th...

Campus Vienna Biocenter 3

Vienna,  1030


254 Employees


43 1 20620


43 1 20620 800

Key Executives for Intercell Ag

Intercell Ag does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
ProCeryon Biosciences GmbH Europe
Novogenia GmbH Europe
Austrianni GmbH Europe
Hookipa Biotech GmbH Europe
Panoptes Pharma GES.M.B.H Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intercell Ag, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at